IL-17A in the Psoriatic Patients’ Serum and Plaque Scales as Potential Marker of the Diseases Severity and Obesity

Table 1

Characteristics of studied groups.

Variable	Psoriatic patients				Control group
	Min	Max	M	SD	Min	Max	M	SD
Age (years)	26	76	50.14	14.51	27	75	46.85	13.44
BMI	18.8	46.1	27.32	5.30	20.68	30.19	24.81	3.09
Age of psoriasis onset (years)	1	71	29.29	17.37
Duration of psoriasis (years)	5	44	20.86	12.82
PASI	10	47	24.52	10.36
PGA	3	5	3.76	0.89
BSA (%)	13	90	42.6	25.29
NAPSI	0	80	23.43	19.82
DLQI	6	30	18.62	7.76
Il-17 serum concentration	0.54	11.23	4.24	3.69	1.21	6.23	3.06	1.19
IL-17 scale concentration	14.74	181.57	68.32	51.68